Control of gene expression in intestinal cells is poorly understood. Molecular mechanisms that regulate transcription of cellular genes are the foundation for understanding developmental and differentiation events. Mucin gene expression has been shown to be altered in many intestinal diseases and especially cancers of the gastrointestinal tract. Towards understanding the transcriptional regulation of a member of the 11p15.5 human mucin gene cluster, we have characterized 3.55 kb of the 5h-flanking region of the human mucin gene MUC5B, including the promoter, the first two exons and the first intron. We report here the promoter activity of successively 5h-truncated sections of 956 bases of this region by fusing it to the coding region of a luciferase reporter gene. The transcription start site was determined by primer-extension analysis. The region upstream of the transcription start site is characterized by the presence of a TATA box at bases k32\k26, DNA-binding elements for transcription factors c-Myc, N-Myc, Sp1 and nuclear factor κB as well as putative activator protein (AP)-1-, cAMPresponse-element-binding protein (CREB)-, hepatocyte nuclear
INTRODUCTION
Human mucins are the main glycoprotein component of epithelial secretions and play important roles in maintaining mucosae integrity. So far, eight genes have been described [1] and among them MUC6-MUC2-MUC5AC-MUC5B are clustered on human chromosome 11p15.5 [2] . Previous studies have demonstrated that the expression of these four genes is tissue-and cell-specific, and that their expression is dysregulated during the pathogenesis of several diseases [3] . These results suggest that mucin gene expression is tightly regulated. MUC5B is mainly expressed in normal bronchus, submaxillary glands, endocervix, pancreas [4] and gall bladder [5, 6] . Interestingly enough, MUC5B has been shown to be highly expressed in colon cancer [3] and especially in the mucus-secreting colon cancer cell lines HT-29 MTX (methotrexate) [7] and LS174T [6] .
The MUC5B gene is 39.09 kb in length, contains 49 exons and encodes a 5701-amino-acid polypeptide with an M r of approx. 627 000. MUC5B shows extensive similarity in its 5h and 3h regions to the other genes of the cluster MUC2, MUC5AC and MUC6 [8] [9] [10] [11] . Regarding MUC5B regulation, we showed previously that intron G, now called intron 37 (30 kb downstream of the ATG), contains eight repeats of a perfect Sp1 (GGGCGG)-binding site [9] . It binds Sp1 and a 42-kDa nuclear factor called NF1-MUC5B specific to the mucus-secreting colon cancer cell line HT-29 MTX [12] .
Abbreviations used : GAPDH, glyceraldehyde-3-phosphate dehydrogenase ; MTX, methotrexate ; STD, standard ; RT, reverse transcriptase ; NF-κB, nuclear factor κB ; AP, activator protein ; UTR, untranslated region ; GRE, glucocorticoid receptor element ; HNF, hepatocyte nuclear factor ; GKLF, gutenriched Kru$ ppel factor ; TTF, thyroid transcription factor. 1 To whom correspondence should be addressed (e-mail vanseuni!lille.inserm.fr).
The nucleotide sequences reported here have been submitted to GenBank under the accession numbers AJ011582 and AJ012453.
factor (HNF)-1-, HNF-3-, TGT3-, gut-enriched Kru$ ppel factor (GKLF)-, thyroid transcription factor (TTF)-1-and glucocorticoid receptor element (GRE)-binding sites. Intron 1 of MUC5B was also characterized, it is 2511 nucleotides long and contains a DNA segment of 259 bp in which are clustered eight tandemly repeated GA boxes and a CACCC box that bind Sp1. AP-2α and GATA-1 nuclear factors were also shown to bind to their respective cognate elements in intron 1. In transfection studies the MUC5B promoter showed a cell-specific activity as it is very active in mucus-secreting LS174T cells, whereas it is inactive in Caco-2 enterocytes and HT-29 STD (standard) undifferentiated cells. Within the promoter, maximal transcription activity was found in a segment covering the first 223 bp upstream of the transcription start site. Finally, in co-transfection experiments a transactivating effect of Sp1 on to MUC5B promoter was seen in LS174T and Caco-2 cells.
Key words : differentiation, LS174T, Myc, Sp1, transcription.
Regarding the other 11p15.5 mucin genes, promoter sequences and transcriptional regulation are known for MUC2 and MUC5AC. MUC2 a prominent mucin gene expressed in the colon, has a TATA and a CCAAT box as well as predicted binding sites for many transcription factors [13, 14] . Transfection studies carried out in colon cancer cell lines (HT-29, LS174T) showed that a region in the promoter of MUC2 that extends 848 bp upstream of the ATG confers maximal transcriptional activity [13] . Gum et al. showed that a short segment including bases k91\k73 relative to the start site was essential for basal promoter activity in several colon cancer cell lines [14] . By the means of transgenesis, the same group showed that cis-elements necessary for MUC2 goblet-cell-specific expression are present within the MUC2 promoter [15] . More recently, it was shown that Sp1 regulates rat muc2 gene transcription in lung cells [16] . Li et al. showed that Pseudomonas aeruginosa lipopolysaccharide activates a c-Src-Ras-MEK 1\2-pp90rsk signalling pathway that leads to activation of nuclear factor κB (NF-κB ; p65\p50) [17] . Activated NF-κB binds to κB sites in the 5h proximal region of the gene and induces MUC2 transcription [18, 19] .
MUC5AC is highly expressed in airway epithelial cells and in the stomach. A TATA box is located at k23\k29 of the transcription start site and putative binding sites for Sp1, activator protein (AP)-2, glucocorticoid receptor element (GRE), NF-κB as well as a CACCC box were found within the promoter [20] . MUC5AC transcription is activated when bronchial ex-plants, airway epithelial cells (NCIH292) or colon cancer cells (HM3) are exposed to P. aeruginosa or its exoproducts in cell-free supernatants. Both MUC2 and MUC5AC are upregulated by other Gram-positive and Gram-negative organisms [20] . These results suggest that the pathology of cystic fibrosis bacterial infection increases MUC2 and MUC5AC mucin mRNA production.
In this report, we present the genomic sequence of 3.55 kb of the MUC5B 5h-flanking region that includes the promoter and the first intron. The promoter and first intron were characterized and several important cis-elements that bind nuclear factors (Sp1, N-Myc, NF-κB, TGT3, AP-2α and GATA-1) were identified. MUC5B transcriptional activity was studied in colon cancer cell lines that are undifferentiated [HT-29 STD (standard)] or that either differentiate in mucus-secreting cells (LS174T) or in enterocytes (Caco-2). It appears that MUC5B expression shows cell-specificity and is the highest in mucus-secreting colon cancer cell line LS174T. The roles of the structural and functional properties of the MUC5B promoter in MUC5B gene transcription are discussed.
MATERIALS AND METHODS

Cloning
Inserts were prepared using the restriction map of two cosmid clones called ELO9 [21] and BEN1 [8] , which cover the 5h proximal region of MUC5B. Gel-purified fragments (Qiaquick gel extraction kit, Qiagen) were subcloned into the promoterless pGL3 Basic vector (Promega). Internal deletion mutants were generated by PCR using pairs of primers bearing specific restriction sites at their 5h and 3h ends. PCR products were digested, gel-purified and subcloned into the pGL3 vector that has previously been cut with the same restriction enzymes. All clones were sequenced on both strands on an automatic LI-COR sequencer (ScienceTec, France) using infrared-labelled RV3 and GL2 primers (Promega). Plasmids used for transfection studies were prepared using the Endofree plasmid Mega kit (Qiagen).
Cell culture
The LS174T cell line was cultured in a 37 mC incubator with 5 % CO # in Dulbecco's modified Eagle's minimal essential medium supplemented with non-essential amino acids and 10 % foetal calf serum (Boehringer Mannheim). Other human colon adenocarcinoma cell lines were cultured in a 37 mC incubator with 10 % CO # in Dulbecco's modified Eagle's medium supplemented with either 10 % (HT-29 STD, HT-29 MTX) or 20 % (Caco-2) foetal calf serum. All cell lines were a kind gift from Dr A. Zweibaum (Unite! INSERM Nm178, Villejuif, France).
Reverse transcriptase PCR (RT-PCR)
Total RNAs from colon cancer cells were prepared using the RNeasy midi-kit from Qiagen. Cells were harvested at 70 % confluence and 1.5 µg of total RNA was used to prepare cDNA (Advantage4 RT-for-PCR kit, Clontech). PCR was then performed on 5 µl of cDNA using specific pairs of primers for MUC2 and MUC5B mucin genes (M.-P. Buisine, N. Moniaux, S. Nollet, E. Destailleur, I. Van Seuningen, A. Laine, N. Porchet and J.-P. Aubert, unpublished work) : MUC2 forward primer, 5h-CTGCACCAAGACCGTCCTCATG-3h ; MUC2 reverse primer, 5h-GCAAGGACTGAACAAAGACTCAGAC-3h (positions nt 15291-15312 and nt 15667-15691, accession number L21998 [22] ) ; MUC5B forward primer, 5h-CTGCGAGACCGAGGT-CAACATC-3h ; MUC5B reverse primer, 5h-TGGGCAGCAGG-AGCACGGAG-3h (positions nt 9057-9078 and nt 10108-10127, 
Primer extension
Primer-extension reactions were performed using 25 µg of total RNA isolated from LS174T and HT-29 MTX cell lines. Primers were end-labelled with [γ-$#P]dATP. Exon 1 reverse primer, 5h-TGCCTGCGGCACCACGAGCATG-3h (see Figure 2B below) was annealed to RNA at 62 mC for 20 min followed by a 10 min incubation at room temperature. Extension was performed as described in the Promega primer-extension kit using 200 units of Moloney-murine-leukaemia virus (MMLV) RT (Advantage4 RT-for-PCR kit, Clontech) for 45 min at 42 mC. Reactions were stopped by adding 20 µl of loading buffer (98 % formamide\ 10 mM EDTA\0.1 % xylene cyanol\0.1 % Bromophenol Blue). φX174 DNA\HinfI dephosphorylated markers were radiolabelled with [γ-$#P]dATP just before use (Promega). Manual sequencing of fragment 1429 (DNA fragment of MUC5B promoter region) was performed using the T7 Sequenase version 2.0 kit (Amersham). Samples were denatured for 10 min at 90 mC before loading on a 6 % sequencing gel (Sequagel-6, National Diagnostic). The gel was then vacuum-dried and autoradiographed for 3-4 days at k80 mC.
Oligonucleotides and DNA fragments
Oligonucleotides used for PCR are shown in Table 1 . Those used for gel-shift assays are indicated in Table 2 . They were synthesized by MWG-Biotech. Annealed oligonucleotides were radiolabelled using T4 polynucleotide kinase (Promega) and [γ-$#P]dATP. Radiolabelled probes were separated from free nucleotides on Sephadex G-25 columns (Boehringer Mannheim). DNA fragment 1472 was produced by PCR (forward primer, 5h-CGCG-AGCTCGATAACCAAGGGCAGTCA-3h ; reverse primer, 5h-CGCACGCGTTCCACCCCGACCCACAGC-3h) and cloned into the pGL3 vector. This fragment contains the eight GA boxes found in intron 1. The fragment was cut out of the vector by SacI-MluI double digestion, gel-purified and labelled with [α-$#P]dCTP at the 3h end by a fill-in reaction using the Klenow fragment (Boehringer Mannheim).
Transfections
Cells from the human colon adenocarcinoma cell lines HT-29 STD (parental undifferentiated cell line), Caco-2 (enterocytes) and LS174T (goblet cells, mucus-secreting) were electroporated using Gene Pulser II apparatus (Bio-Rad) on day 7 (70 % confluence). Before electroporation, 25 µg of plasmid were added to the cells. In co-transfection experiments, 20 µg of pGL3 deletion mutant and 5 µg of pCMV-Sp1 or pCMV-Sp3 were used. After a 10-min incubation at room temperature, transfected cells were plated and incubated for 48 h at 37 mC. Total cell extracts were prepared using 1iReagent Lysis Buffer (Promega) as described in the manufacturer's instruction manual. Results were corrected for transfection efficiency by co-transfecting 2 µg of pSV-βGal vector (Promega). β-Galactosidase activity was measured in 96-well plates as described in the manufacturer's instruction manual using 50 µl of cell extracts (Promega). Luciferase activity was measured on a Berthold 5901 luminometer on 100 µl of cell extracts using luciferase assay reagent (Promega). The luciferase activity is expressed as fold induction of the test plasmid activity compared with that of the corresponding control vector (pGL3 control, Promega) after correction for transfection efficiency by dividing by β-galactosidase activity. Each plasmid was assayed in duplicate in at least three separate experiments. pCMV4, pCMV4-Sp1 and pCMV4-Sp3 vectors were a kind gift from Dr J. M. Horowitz (North Carolina State University, Raleigh, NC, U.S.A.).
Nuclear-extract preparation
Nuclear extracts from cell lines of interest were prepared as described in [23] , and kept at k80 mC until use. Protein content (5 µl of cell extracts) was measured using the bicinchoninic acid method in 96-well plates, as described in the manufacturer's instruction manual (Pierce).
Gel-shift assays
Nuclear proteins (5 µg) were pre-incubated for 20 min on ice in 20 µl of binding buffer with 2 µg of poly dI-dC (Sigma) and 1 µg of sonicated salmon sperm DNA. Radiolabelled DNA probe was added (120 000 c.p.m.\reaction) and the reaction left for another 20 min on ice. For super-shift analyses, 1 µl of the antibody of interest (anti-Sp1, anti-AP2α, anti-GATA-1, anti-cMyc, anti-N-Myc, anti-Max, anti-c-Fos, anti-NF-κB p50 and anti-NF-κB p65, Santa Cruz Laboratories) was added to the proteins and left for 1 h on ice before adding the radiolabelled probe. Negative controls were carried out using 1 µl of irrelevant antibody in the reaction mixture. Competitions were performed with 50-, 150-and 300-fold excesses of unlabelled oligonucleotide in the reaction mixture before adding the radiolabelled probe. Commercial Sp1 oligonucleotide and Hela-cell nuclear extract used as positive controls were from Promega. The reactions were stopped by adding 2 µl of loading buffer, loaded on to a 4 % nondenaturing polyacrylamide gel (for oligonucleotides) and electrophoresis conditions were as described in [24] . Gels were pre-run for 30 min at 200 V before loading the samples and running the electrophoresis at 200 V for 2-3 h in 0.5iTris\borate\EDTA buffer at 4 mC. For DNA probes longer than 250 bp (1472), 6 % gels were run as described in [25] , with slight modifications : the pre-run was 1 h and 15 min long and electrophoresis was run for 4 h and 15 min at 4 mC. Gels were then vacuum-dried and autoradiographed overnight at k80 mC.
Southwestern-and immuno-blotting
Nuclear proteins (25 µg) were resolved by SDS\PAGE (10 % gel) and then electrotransferred on to a nitrocellulose membrane (pore size 0.22 µm, Schleicher and Schuell). Proteins were submitted to a denaturation\renaturation cycle as described by Jackson [26] before radiolabelled probe (1i10' c.p.m.\ml of buffer) was added to the mixture and left for 30 min at room temperature. When necessary, unlabelled competitor (150-fold excess) was pre-incubated with the membrane before adding the radiolabelled probe. The membrane was then washed and autoradiographed overnight at k80 mC. The radiolabelled probe was washed off by incubating the membrane twice for 5 min in boiling 0.1iSSC\0.1 % SDS solution (where 1iSSC is 0.15 M NaCl\0.015 M sodium citrate) and rinsed once with 3iSSC.
Immunostaining was then performed using the anti-Sp1 antibody PEP2 (Santa Cruz Laboratories) at a 1 : 1000 dilution. Alkaline phosphatase-conjugated goat anti-rabbit antibody (Promega) was used at a 1 : 4725 dilution. Protein bands were developed using Nitro Blue Tetrazolium chloride and 5-bromo-4-chloro-3-indolylphosphate p-toluidine salt (Life Technologies) as chromogenic substrates for alkaline phosphatase. Prestained protein molecular-mass standards were from Life Technologies.
DNA sequence and transcription-factor-binding site analyses
DNA sequences were analysed using PC-GENE software and the TRANSFAC database [27] was used to define potential transcription-factor-binding sites within the clones of interest. The search was conducted using MatInspector V2.2 software [27] . 
RESULTS
DNA sequence and characterization of MUC5B 5h-flanking region
Two genomic clones, ELO9 and BEN1, which we previously isolated to study MUC5B and MUC5AC gene organization [9, 21] , were used in this work to characterize the 5h-flanking region of MUC5B. Here, we report the genomic sequence obtained and an analysis of transcriptional activity of the 5h-flanking region including 956 bases of DNA sequence located upstream of the transcriptional start site as well as 2637 bases downstream that include the first two exons and the first intron. Between the transcription start site and the ATG codon coding for the first methionine lies the 5h untranslated region (UTR) of 56 nucleotides ( Figure 1A ). The first exon encodes the first 23 amino acids (MGAPSACRTLVLALAAMLVVPQA) and is separated from exon 2, which is composed of 19 amino acids
Figure 3 Mucin gene-expression profiles in colon cancer cells by RT-PCR
RT-PCR was performed on total RNA extracted from cells at day 7. Specific oligonucleotides for MUC2 and MUC5B generate 401-and 415-bp PCR products, respectively. The GAPDH PCR product is 980 bp long. PCR products were separated on a 2 % agarose gel. Molecular-mass markers are shown on the right. (ETQGPVEPSWGNAGHTMDG), by an intron of 2511 nucleotides ( Figure 1B) . Analysis of the DNA sequence using PC-GENE software and the TRANSFAC database [27] showed that the 5h-flanking region upstream of the transcription start site contained a TATAbox-like sequence TACATAA located at bases k32\k26 upstream of the transcription start site ( Figure 1A ). In the close vicinity to the TATA-box-like sequence were found potential binding sites for c-Myc\N-Myc\Max transcription factors (consensus CACGTG), Sp1 and numerous GC and CACCC boxes. It is of interest to note that GC and CACCC boxes are always clustered. Further upstream, putative binding sites were found for AP-1, NF-κB, CCAAT, cAMP-response-element-binding protein (CREB) and GRE transcription factors as well as for a silencer called CIIS1. A striking feature was the presence, throughout the 5h-flanking region upstream of the TATA box, of numerous putative binding sites for transcription factors known to be involved in intestinal [hepatocyte nuclear factor (HNF)-1, HNF-3, TGT3, gut-enriched Kru$ ppel factor (GKLF)] or respiratory [HNF-3, thyroid transcription factor (TTF)-1] cell differentiation. Numerous HpaII sites that could be potential methylation sites were found, two of them being located in the 5h-UTR region.
In the first intron ( Figure 1B ), a high amount of GC boxes, Sp1 binding sites and CACCC boxes were present. More MUC5B gene expression in colon cancer cells importantly, in the central part of the intron were found clustered a CACCC box followed by an array of eight GA boxes repeated in tandem containing the consensus sequence GGGGAGG-GGCT, each separated by 8-10 bp. Other putative sites for known transcription factors are shown in Figure 1 (B) and include three canonical Sp1 binding sites, two AP-2 sites, one NF-κB site, one GATA-1 site and one Adh-1 site.
Characterization of the MUC5B transcription start site
Primer-extension reactions were performed using RNAs from the two mucus-secreting colon cancer cell lines LS174T and HT-29 MTX to identify the transcription start site in the MUC5B 5h-flanking region. These two cell lines were chosen as they both express MUC5B. The result, shown in Figure 2(A) , indicates that the reactions carried out with reverse primer E1 localized in exon 1 (sequence underlined in Figure 2B ) produced one extension product of the same size (126 bp) in both cell lines. In the sequence, the start site matches a cytosine residue that we numbered j1. The 5h-UTR region is 56 nucleotides long ( Figure  2B ).
MUC5B gene expression in LS174T, Caco-2 and HT-29 STD colon cancer cells
To investigate the cell-specific expression of MUC5B, three colon cancer cell lines showing different phenotypes were chosen : the mucus-secreting LS174T, the Caco-2 enterocyte and the undifferentiated HT-29 STD cell lines. MUC2 expression was studied in parallel as a positive control of RT-PCR as it is the main mucin expressed in colon. MUC5B (415-bp PCR product) and MUC2 (401-bp PCR product) mRNA expression was studied by RT-PCR from 70 % confluent cells in order to correlate RT-PCR results with transfection experiments. As shown in Figure 3 , undifferentiated cell line HT-29 STD slightly expresses MUC2 and MUC5B mRNAs. Caco-2 cells that spontaneously differentiate in enterocytes also show a very low expression of the two genes. Overall, in these two cell lines, mucin gene expression remains very discrete when compared with the GAPDH internal control. On the other hand, MUC2 and MUC5B are highly expressed in the mucus-secreting cell line LS174T. The level of expression of both genes is maximal after cells have differentiated into mucus-secreting cells. Moreover, one can notice that MUC2 and MUC5B follow the same pattern of expression in the three colon cancer cell lines studied.
Promoter activity of the MUC5B 5h-flanking region
In order to identify DNA sequences involved in MUC5B transcriptional regulation, constructs were generated in the promoterless pGL3 Basic vector and analysed for transcriptional activity after cell electroporation. Insert sequences were confirmed by infrared sequencing of both strands and aligned with ELO9 and BEN1 sequences. Transfection experiments on deletion fragments of the MUC5B promoter were carried out in Caco-2, LS174T and HT-29 STD cell lines. Seven fragments were generated that cover 956 nucleotides upstream of the transcription start site ( Figure 4A ). The fragments 1916, 1896, 1597 and 1596 contain the TATA-box-like sequence (TACATAA), the three Sp1-binding sites and the CACCC box. In fragments 1916 and 1597, the 5h-UTR region was included. In LS174T cells, the MUC5B 5h-flanking region shows a highly active promoter activity. In these cells, the fragment 1896 that covers the whole region shows a lower luciferase activity when compared with the region restricted to the first 223 nucleotides upstream of the transcription start site (1596 ; Figure 4B ). Interestingly enough, when the 5h-UTR region was included in the fragments corresponding to the whole region (1916) or to the 223 first bases (1597), luciferase activity dropped by approx. 2-fold. This result indicates that the 5h-UTR region of MUC5B plays a role in regulating promoter activity. In conclusion, the first 223 bp (fragment 1596) adjoining the transcription start site suffice to drive basal promoter activity of the luciferase reporter gene. Three other deletion mutants were then constructed to identify a potential inhibitory domain in the promoter that would explain the low luciferase activity of the fragment 1896. Fragment 1895 covers the upstream 734 bases (k956\k223) and fragments 1595 and 1598 include bases k446\k223 and k956\k441, respectively. Experiments show that in all cell lines 1595 has no activity whereas fragments 1895 and 1598 act as inhibitory domains. Thus this result confirms the fact that inhibitory factors bind to cis-elements present in the k956\k441 region of the promoter. Finally, MUC5B promoter activity is minimal in Caco-2 and HT-29 STD cell lines when compared with that in LS174T cells.
Binding studies of MUC5B promoter with nuclear proteins
In order to characterize cis-elements and trans-nuclear factors that could account for MUC5B transcription regulation in colon MUC5B gene expression in colon cancer cells
Figure 7 AP-2α and GATA-1 transcription factors bind to the first intron of MUC5B
Autoradiogram of the gel-shift assay in which radiolabelled oligonucleotides including the AP-2- (lanes 1-4) and GATA-1-(lanes 5-8) binding sites found in intron 1 were incubated with 5 µg of Caco-2 nuclear extracts in the absence (lanes 2 and 6) or presence (lanes 3-5 and 8) of 1 µl of specific antibody as indicated. Radiolabelled probe alone (lanes 1 and 7) .
cancer cells, electrophoretic mobility-shift assays were carried out with double-stranded DNA probes containing binding sites for specific nuclear factors ( Figure 5 ). In Figure 5 (A), two retarded bands (lanes 1 and 2) were obtained when Caco-2 nuclear extracts were incubated with the double-stranded oligonucleotide comprising the c-Myc\N-Myc\Max putative binding site ( Figure 5A, lane 2) . Addition of c-Myc or N-Myc antibodies prior to the radiolabelled probe dramatically reduced the intensity of complex no. 1 but had no effect on complex no. 2 ( Figure 5A,  lanes 3 and 4) . On the other hand, addition of the Max antibody had no effect ( Figure 5A, lane 5) . Complex no. 1 was not visualized in LS174T cells ( Figure 5A, lanes 7-10) . Sp1 binds to the CACCC box in both cell lines (complex no. 3) as addition of Sp1 antibody resulted in a totally super-shifted complex (band no. 4, Figure 5A, lanes 11-14) .
In Figure 5 (B) is shown the binding of NF-κB (lanes 1-7) . When Caco-2 nuclear proteins were incubated with the doublestranded oligonucleotide containing the putative NF-κB binding site ( Figure 5B, lane 2) , three retarded bands were visualized on the autoradiogram (bands 1-3 ). When incubated with LS174T nuclear proteins ( Figure 5B , lane 5) only bands 1 and 3 could be seen. Upon addition of the specific NF-κB p50 antibody ( Figure   5B, lane 3) , complexes 2 and 3 were abolished. With the antibody directed against the NF-κB p65 subunit, only complex 2 disappeared. Complex 1 is therefore due to an interaction with another nuclear protein since the addition of these two antibodies did not have any effect on the shifted band. Binding studies with the TGT3 putative binding site ( Figure 5B, lanes 8-10) resulted in two high-mobility retarded bands with Caco-2 nuclear proteins ( Figure 5B , lane 9, complexes 5 and 6) but only one lowmobility-shifted band with LS174T nuclear extracts ( Figure 5B,  lane 10, complex 4) .
In Figure 5 (C), studies with the CCAAT DNA probe showed one retarded band with Caco-2 nuclear extracts (lane 2, complex 1). Two more retarded bands with a higher mobility (complexes 2 and 3) were visualized when incubated with LS174T nuclear extracts (lane 3).
Binding studies of MUC5B first intron with nuclear proteins
Given that first introns have been shown to play roles in the regulation of tissue-specific intestinal genes, we investigated whether such potential DNA-binding cis-elements could be found in MUC5B's rather large (2.5 kb) first intron. A highly striking feature was the presence of eight clustered GA boxes repeated in tandem located near to a CACCC box. All these cis-elements represent potential binding sites for the ubiquitous nuclear factor Sp1. Gel-shift-assay experiments were performed with nuclear extracts from the three cell lines of interest. As they gave the same results only those with LS174T nuclear proteins are shown. When we used double-stranded DNA representative of the CACCC box one low-mobility retarded band was visualized (complex 1, Figure 6A , lane 2) that was totally super-shifted when an anti-Sp1 antibody was added in the reaction mixture ( Figure 6A, lane 6) . The same result was obtained with the double-stranded oligonucleotide containing the GA-box consensus sequence GGGGAGGGGCT ( Figure 6A, lanes 3 and 7) . A similar experiment conducted with an oligonucleotide containing an Sp1 found in the 3h region of the intron did not produce any retarded bands ( Figure 6A, lanes 4 and 8) .
In order to confirm the binding of Sp1 to the GA boxes, Southwestern-and immuno-blotting studies were performed ( Figure 6B ). The nuclear protein recognized by the radioactive GA-box DNA probe shows an M r of around 95 000 in the three cell lines ( Figure 6B, lanes 7-9) . When ' cold ' competition was performed with a 150-fold excess of the unlabelled GA-box DNA probe the signal was almost totally abolished, demonstrating the specificity of the interaction ( Figure 6B, lanes 10-12) . As a positive control for Sp1 binding, the blot was then probed with a DNA probe representative of one of the Sp1-binding sites present in MUC5B promoter (see Figure 5A, lanes 11-14) . The same band was visualized ( Figure 6B, lanes 1-3) and ' cold ' competition also resulted in the loss of the signal ( Figure 6B , lanes 4-6). The same blot was then probed with the anti-Sp1 antibody ( Figure 6B, lanes 13-15) . The band visualized after immunostaining could be superimposed on the radioactive band obtained from the Southwestern-blotting study, confirming the fact that Sp1 binds to the GA box. We can conclude from these results that the Sp1 nuclear factor engages with the CACCC and GA boxes found in MUC5B intron 1. It is likely that the other seven GA boxes that contain the same consensus sequence GGGGAGGGCT also interact with Sp1.
To verify this hypothesis, gel-shift experiments were performed using the fragment 1472 that contains the eight GA boxes as the DNA probe. Figure 6 (C) shows that the shifted band obtained when 1472 was incubated with nuclear proteins from LS174T cells ( Figure 6C , lane 2, complex 1) was completely super-shifted when the anti-Sp1 antibody was added to the reaction mixture ( Figure 6C, lane 3, complex 2) . The shift was shown to be specific by performing competition experiments with unlabelled DNA fragment 1472 ( Figure 6C , lanes 4-6) or unlabelled GA box oligonucleotide ( Figure 6C, lanes 7-9) as competitors. The shift is almost totally inhibited when competitors are added at a molar ratio of 150 ( Figure 6C , lanes 5 and 8) and totally disappears at a ratio of 300 ( Figure 6C, lanes 6 and 9) . Using mutated oligonucleotides with a modified GA-box sequence (see Table 2 ) only produced a partial inhibition of the retarded band ( Figure  6C, lanes 10-12) .
Among the other predicted binding sites present in intron 1, we studied NF-κB, AP-2 and GATA-1 binding (Figure 7) . Two shifted bands were obtained when Caco-2 nuclear proteins were incubated with the AP-2 oligonucleotide ( Figure 7 , lane 2). Of these two bands, the upper one disappeared upon addition of the anti-AP-2α antibody ( Figure 7, lane 3) . The specificity of the binding was confirmed by the absence of any effect when an irrelevant anti-c-Fos antibody was used ( Figure 7, lane 4) . Complex 1 was not seen in LS174T cells (results not shown). When we used the double-stranded GATA oligonucleotide, one shifted band (complex 3) was visualized with Caco-2 nuclear proteins ( Figure 7, lane 6) . The intensity of the shifted band decreased substantially when an anti-GATA-1 antibody was added to the reaction mixture ( Figure 7 , lane 5), whereas there was no effect with the anti-Sp1 antibody ( Figure 7, lane 8) . No shift was visualized with the NF-κB oligonucleotide in either cell line (results not shown).
Sp1 transactivation of the MUC5B promoter
In order to demonstrate the active participation of Sp1 in MUC5B promoter activity, co-transfection experiments were performed in the three cell lines of interest. Sp3, another member of the Sp family known to compete with Sp1 for the same binding sites, was also studied (Figure 8 ). Co-transfection of Sp1 with fragment 1896 (k956\k1) led to an increase in luciferase activity in LS174T and Caco-2 cells (2-and 3.5-fold, respectively), whereas co-transfection with Sp3 led to a slight decrease of activity in LS174T cells and had no effect in Caco-2 cells. When the same experiments were conducted with the fragment 1596 (k223\k1), no significant effect was observed in either cell line. In HT-29 STD cells, co-transfection with Sp1 had no effect, whereas co-transfection with Sp3 dramatically decreased the luciferase activity of both fragments by about 5-fold.
DISCUSSION
Molecular mechanisms involved in the control of gene expression in intestinal cells are still poorly understood. An understanding of the regulatory network of nuclear proteins that direct transcriptional initiation of genes will provide insight into the mechanisms of normal intestinal development and differentiation as well as disease processes such as neoplasia [28] . Since mucins are the main components of human epithelial secretions, responsible for the mucus rheology and physical properties, and since mucin genes display altered expression in neoplastic and pre-neoplastic processes affecting the colon [3, 29] , it is essential to understand the molecular mechanisms that prevail to their expression. Thus characterization of the promoter regions as well as the nuclear factors involved in the regulation of mucin gene expression is necessary.
In order to identify regulatory regions involved in MUC5B transcription, the MUC5B promoter region as well as the first intron have been sequenced and analysed. Transcriptional activity was studied in three colon cancer cell lines and transcription-factor binding to cis-elements present in either the promoter or the first intron were identified. The 5h-flanking region upstream of the transcriptional start site revealed the presence of a TATA-like sequence TACATAA at k26\k32, which is a characteristic of tissue-specific genes. The MUC5B promoter contains a high number of GC and CACCC boxes that are known to bind Sp1. In this study, Sp1 binding was demonstrated to occur in this region in the three cell lines. Involvement of Sp1 in regulation of mucin genes has already been shown for MUC1 [30] and MUC2 [13, 14] . Also in this study, the transactivating effect of Sp1 on the MUC5B promoter was shown to be effective on the whole promoter region but not on the fragment containing the first 223 nucleotides adjacent to the TATA box. This result may be explained by the fact that other transcription factors or epigenetic mechanisms like methylation are required to mediate Sp1 activity. In the MUC5B promoter, Sp1 binding sites were often found to be nearby binding sites for other specific factors. This phenomenon usually indicates that the clustered factors act in conjunction with each other to modulate transcription [31] . Among the other factors, NF-κB may be a good candidate as it has already been shown to increase MUC2-promoter activity in epithelial cells via an Srcdependent pathway in response to bacterial exoproducts [18] . The MUC5B promoter contains a κB element that binds NF-κB in Caco-2 cells. In these cells, N-Myc, c-Myc as well as AP-2 and GATA factors may also control regulation of MUC5B since these factors were shown in this report to bind to the MUC5B promoter and first intron, respectively.
The first intron of MUC5B, whose sequence is described for the first time in this report, is very large (2.5 kb) and contains a striking feature, a central domain of 259 bp, which contains eight GA boxes repeated in tandem. Sp1 was shown to bind throughout this domain suggesting that this domain may serve as a docking platform for Sp1. Such repetitive sequences located in introns of 5h-flanking regions have already been described for human immunoglobin heavy chain, insulin and serotonin transporter genes. However, this type of sequence remains relatively rare in the human genome [32] . They are usually rich in GC and GA residues and induce looping of DNA, and therefore their presence is often associated with a role in regulating gene transcription [32] . Such a role may thus be played by the first intron of MUC5B.
MUC5B-promoter activity was studied in three intestinal cancer cell lines showing different phenotypes in order to address cell-specific activity. The cells were either undifferentiated (HT-29 STD), differentiated in enterocytes (Caco-2) or mucussecreting (LS174T). Clearly, the MUC5B promoter is not active in undifferentiated and enterocyte colon cancer cells. It is however very active in LS174T mucus-secreting cells. This result confirmed our RT-PCR results in which MUC5B mRNA expression was important in LS174T cells and almost absent from HT-29 STD and Caco-2 cells. Our results regarding MUC2 and MUC5B expression in LS174T cells are in good agreement with those published by Van Klinken et al. [33] . A recent study by these authors also showed that MUC2 and MUC5B were expressed in the same subset of colonic cells, that is goblet cells in the crypt base ; co-localized expression was also shown in the small granules within goblet cells [6] . Why the cell needs to express several mucin genes simultaneously is another issue that will have to be addressed. Furthermore, knowledge of the mechanisms that control transcription of the four human mucin genes, MUC6, MUC2, MUC5AC and MUC5B, clustered on the chromosome 11 will certainly help in understanding the role of some regulatory factors in intestinal diseases in which altered expression of mucin genes has already been demonstrated [34] .
Numerous putative binding sites for transcription factors involved in intestinal (HNF-1, HNF-3, three consensus binding sites for TGT3, GKLF) or respiratory (10 consensus binding sites for TTF-1) cell differentiation were found throughout the MUC5B promoter. In situ hybridization studies performed in our laboratory showing early expression of human mucin genes during embryonic and foetal development in intestine and respiratory tracts suggest the involvement of these genes during ontogenesis [35, 36] . Identification of silencers is also important to elucidate MUC5B down-regulation in certain cells. A putative binding site for such a factor, called CIIS1 [37] , was found in the MUC5B promoter in fragments that showed inhibitory activity (1895 and 1598).
In conclusion, we have characterized the 5h-flanking region of MUC5B and shown that promoter activity was the highest in mucus-secreting cells. Important features and cis-elements that bind specific transcription factors were identified in the promoter (TATA box, Sp1, NF-κB, c-Myc and N-Myc) and the first intron (Sp1, GATA-1 and AP-2α) of MUC5B that might account for the cell-specific expression pattern of that gene. We also showed that Sp1 is involved in the regulation of MUC5B promoter activity. Experiments are now in progress to identify transcription factors and cell-signalling pathways responsible for the altered expression of MUC5B in intestinal diseases. Of particular interest will be the deciphering of the molecular mechanisms implicating the MUC5B gene in gastrointestinal cell differentiation. Moreover, experiments are now in progress to determine the influence of intron 1 and of intron 37, which has already been shown to bind Sp1 and NF1-MUC5B nuclear factors [12] , on MUC5B promoter activity.
